{"nct_id":"NCT01648101","title":"Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures","status":"TERMINATED","status_verified_date":"2018-06","start_date":"2012-08-29","start_date_type":null,"primary_completion_date":"2013-12-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-12-23","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}